Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

TechMARK movers: Restructuring costs hit Sinclair figures

Thu, 25th Feb 2010 14:36
Sinclair Pharma shares fell after it reported a slump into loss in 2009 but much of that was due to restructuring costs. However, another large loss is expected this year. New chief executive Chris Spooner has wasted little time in restructuring the business and boosting the sales expertise in the group. He ended Sinclair's distribution agreement with Orapharma Inc for Decapinol mouth rinse and plans to find another partner covering more of the market.Sinclair has negotiated new debt facilities of £9m and raised £18.2m from a share placing. The cash was used to finance the acquisition of Flammazine and Flammacerium (used for topical treatment of burns) from Solvay Pharmaceuticals for £16.8m. Sinclair had net debt of £12.3m at the end of 2009.Revenues were one-third lower than last year at £11m. Stripping out one-off payments, underlying revenues were 1% lower. Sinclair made a profit of £3.17m in 2008 but that was down to foreign exchange gains. The 2009 loss was £14.5m and around two-thirds of this was due to impairment charges and restructuring costs. Broker Singer has increased its forecast loss for 2010 from £6.1m to £15m. Stripping out exceptional charges the forecast loss rises from £1.7m to £2m. Singer has a 41p a share price target and says it believes that "the company is now better placed to deliver long term financial growth". Shares in IT services provider Logica are recovering following yesterday's fall on the announcement of figures for 2009. Revenues are expected to fall in the first half of 2010 and be flat for the year as a whole. FTSE TechMARK - RisersVisonic (VSC) 82.00p +2.50%Psion (PON) 92.00p +2.22%Ark Therapeutics (AKT) 14.50p +1.75%NXT (NTX) 14.75p +1.72%BT Group (BT.A) 117.60p +1.29%Intec Telecom Systems (ITL) 98.00p +1.29%COLT Telecom Group S.A. (COLT) 136.50p +1.11%Logica (LOG) 118.20p +1.11%Vodafone Group (VOD) 142.20p +0.85%Anite Group (AIE) 32.50p +0.78%FTSE TechMARK - FallersRenovo Group (RNVO) 27.25p -6.03%Sinclair Pharma (SPH) 29.50p -4.84%Oxford Instruments (OXIG) 232.00p -4.13%Gresham Computing (GHT) 19.00p -3.80%Vernalis (VER) 73.50p -3.61%Morse (MOR) 40.00p -2.44%Phoenix IT Group (PNX) 275.00p -2.22%Innovation Group (TIG) 12.50p -1.96%XP Power (XPP) 425.00p -1.96%Consort Medical (CSRT) 356.00p -1.79%

Related News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Sinclair Pharma News

DIRECTOR DEALINGS: Sinclair Non-Executive Acquires Shares
22 Apr 2014

DIRECTOR DEALINGS: Sinclair Non-Executive Acquires Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said Non-Executive Director Stuart Swanson acquired 50,000 shares at a price of 30.50 pence pe...

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Exec Buys 35,000 Shares
22 Apr 2014

DIRECTOR DEALINGS: Sinclair IS Pharma Non-Exec Buys 35,000 Shares

LONDON (Alliance News) - Sinclair IS Pharma PLC Thursday said Non-Executive Director Stuart Swanson bought 35,000 shares at a price of 30.5 pence per ...

Wednesday broker round-up UPDATE
16 Apr 2014

Wednesday broker round-up UPDATE

Afren: Investec cuts target price from 200p to 195p and stays with its buy recommendation. Alexander Mining: Northland lowers target price from 8.1p ...

Sinclair IS Pharma In USD117.0 Million Deal For Silhouette
15 Apr 2014

Sinclair IS Pharma In USD117.0 Million Deal For Silhouette

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said it has agreed a deal to acquire private aesthetics company Silhouette for about USD117.0 ...

Sinclair IS Pharma To Acquire Global Rights To Ellanse In AQTIS Medical Buy
1 Apr 2014

Sinclair IS Pharma To Acquire Global Rights To Ellanse In AQTIS Medical Buy

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said that its has entered into agreements to acquire the global rights to Ellanse, a combined ...

Sinclair IS Pharma To Meet Full Year Expectations, Pretax Loss Narrows
25 Mar 2014

Sinclair IS Pharma To Meet Full Year Expectations, Pretax Loss Narrows

LONDON (Alliance News) - Sinclair IS Pharma PLC Tuesday said it expects its full-year results to meet market expectations, although it saw results "ma...

Sinclair IS Pharma reduces half-year losses
25 Mar 2014

Sinclair IS Pharma reduces half-year losses

- Trims half-year losses - Expects full-year to meet targets - Confident about future progress AIM-listed speciality pharmaceutical company Sinclair ...

Sinclair Pharma reports smaller half-year loss
25 Mar 2014

Sinclair Pharma reports smaller half-year loss

March 25 (Reuters) - Sinclair IS Pharma, which focusses on dermatology, wound care and skin care, reported a smaller loss for the first half as acquis...